PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 145 filers reported holding PROTAGONIST THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $258,689 | -75.3% | 9,366 | -79.4% | 0.00% | -80.0% |
| Q1 2023 | $1,045,879 | +24.5% | 45,473 | -40.9% | 0.01% | +25.0% |
| Q4 2022 | $839,961 | +29.4% | 76,990 | 0.0% | 0.00% | +33.3% |
| Q3 2022 | $649,000 | +15.7% | 76,990 | +8.5% | 0.00% | 0.0% |
| Q2 2022 | $561,000 | -54.3% | 70,930 | +49.7% | 0.00% | -50.0% |
| Q1 2021 | $1,227,000 | +26.8% | 47,387 | -1.3% | 0.01% | +50.0% |
| Q4 2020 | $968,000 | +6.0% | 48,007 | +2.8% | 0.00% | 0.0% |
| Q3 2020 | $913,000 | +10.7% | 46,707 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $825,000 | +300.5% | 46,707 | +60.4% | 0.00% | +300.0% |
| Q1 2020 | $206,000 | – | 29,117 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $56,331,209 | 18.32% |
| Kynam Capital Management, LP | 1,375,000 | $31,625,000 | 4.08% |
| BVF INC/IL | 3,775,900 | $86,845,700 | 3.18% |
| Cormorant Asset Management, LP | 1,700,000 | $39,100 | 2.58% |
| RTW INVESTMENTS, LP | 4,600,799 | $105,818,377 | 2.20% |
| Ghost Tree Capital, LLC | 225,000 | $5,175,000 | 1.53% |
| 683 Capital Management, LLC | 791,000 | $18,193,000 | 1.36% |
| Ikarian Capital, LLC | 211,400 | $4,862,200 | 1.10% |
| Ikarian Capital, LLC | 211,400 | $4,862,200 | 1.10% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 105,486 | $2,426,178 | 1.00% |